BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Selling, General & Admin

Selling, General & Admin expenses for AEZS.

Quarterly SG&A Expenses

$3.04M
↑ 49.73% YoY

As of Jun 30, 2024

Annual SG&A Expenses (TTM)

$10.91M
↑ 26.5% YoY

Trailing 12 months ending Jun 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin